SARS-CoV-2 infection in liver transplant recipients: A complex relationship
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
BAISHIDENG PUBLISHING GROUP INC
Autores
Citação
WORLD JOURNAL OF GASTROENTEROLOGY, v.27, n.44, 2021
Resumo
The recent manuscript reviewed investigations involving liver damage in coronavirus disease 2019 (COVID-19) patients, and COVID-19 in patients with previous chronic hepatological diseases, such as patients with liver graft. The literature presents several conflicting results concerning the anti-SARS-CoV-2 response in patients with solid organ transplants, in liver transplant recipients. Therefore, we would like to humbly state a few points for consideration involving liver transplant recipients and COVID-19, such as the time since transplantation, comorbidities, and immunosuppressive regimens.
Palavras-chave
COVID-19, SARS-CoV-2, Liver transplant, Immunosuppression, Infection, Comorbidities
Referências
- Alberca RW, 2020, AM J TROP MED HYG, V103, P2353, DOI 10.4269/ajtmh.20-1185
- Alberca RW, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.689296
- Alberca RW., 2020, FRONT PHYSIOL
- Ali NM, 2021, TRANSPLANTATION, V105, pE104, DOI 10.1097/TP.0000000000003836
- Beimler J, 2014, INTERNIST, V55, P212, DOI 10.1007/s00108-013-3411-8
- Belli LS, 2021, GASTROENTEROLOGY, V160, P1151, DOI 10.1053/j.gastro.2020.11.045
- Benard, 2021, TRANSPLANTOLOGY, V2, P296, DOI [10.3390/transplantology2030030, DOI 10.3390/TRANSPLANTOLOGY2030030]
- Caballero-Marcos A, 2021, AM J TRANSPLANT, V21, P2876, DOI 10.1111/ajt.16599
- Carbajo-Lozoya J, 2012, VIRUS RES, V165, P112, DOI 10.1016/j.virusres.2012.02.002
- Dumortier J, 2021, CLIN RES HEPATOL GAS, V45, DOI 10.1016/j.clinre.2021.101639
- Eason JD, 2005, TRANSPLANTATION, V79, P1157, DOI 10.1097/01.TP.0000162084.46555.10
- Elias M, 2020, J AM SOC NEPHROL, V31, P2413, DOI 10.1681/ASN.2020050639
- Gaston DC, 2021, AM J TRANSPLANT, V21, P1304, DOI 10.1111/ajt.16357
- Gracia-Ramos AE, 2021, WORLD J GASTROENTERO, V27, P3951, DOI 10.3748/wjg.v27.i26.3951
- Hage R., 2021, TRANSPLANTOLOGY, V2, P229
- Imam A, 2020, ANN TRANSPL, V25, DOI 10.12659/AOT.926196
- Jayant K, 2021, CLIN TRANSPLANT, V35, DOI 10.1111/ctr.14246
- Kulkarni AV, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101025
- Kumar D, 2010, LANCET INFECT DIS, V10, P521, DOI 10.1016/S1473-3099(10)70133-X
- Nacif LS, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1983
- Pereira MR, 2021, TRANSPL INFECT DIS, DOI 10.1111/tid.13637
- Peter AE, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.583777
- Ringer M, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13556
- Singh N, 2014, MANDELL DOUGLAS BENN, P3440
- Szabo G, 2001, J INVEST MED, V49, P442, DOI 10.2310/6650.2001.33789
- Tsuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031465
- Webb GJ, 2020, LANCET GASTROENTEROL, V5, P1008, DOI 10.1016/S2468-1253(20)30271-5
- Webb GJ, 2020, LANCET GASTROENTEROL, V5, P643, DOI 10.1016/S2468-1253(20)30125-4
- Yoshino T, 2010, INFLAMM BOWEL DIS, V16, P2022, DOI 10.1002/ibd.21318
- Zhang HD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01392